<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">35602933</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>24</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Electronic">2589-0042</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>25</Volume>
            <Issue>5</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>20</Day>
            </PubDate>
          </JournalIssue>
          <Title>iScience</Title>
          <ISOAbbreviation>iScience</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Ym1<sup>+</sup> macrophages orchestrate fibrosis, lesion growth, and progression during development of murine pancreatic cancer.</ArticleTitle>
        <Pagination>
          <StartPage>104327</StartPage>
          <MedlinePgn>104327</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">104327</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.isci.2022.104327</ELocationID>
        <Abstract>
          <AbstractText>Desmoplasia around pancreatic lesions is a barrier for immune cells and a hallmark of developing and established pancreatic cancer. However, the contribution of the innate immune system to this process is ill-defined. Using the KC mouse model and primary cells <i>in vitro</i>, we show that alternatively activated macrophages (AAM) crosstalk with pancreatic lesion cells and pancreatic stellate cells (PSCs) to mediate fibrosis and progression of lesions. TGFβ1 secreted by AAM not only drives activation of quiescent PSCs but also in activated PSCs upregulates expression of TIMP1, a factor previously shown as crucial in fibrosis. Once activated, PSCs auto-stimulate proliferation via CXCL12. Furthermore, we found that TIMP1/CD63 signaling mediates PanIN lesion growth and TGFβ1 contributes to a cadherin switch and drives structural collapse of lesions, indicating a potential progression step. Taken together, our data indicate TGFβ1 produced by Ym1+ AAM as a major driver of processes that initiate the development of pancreatic cancer.</AbstractText>
          <CopyrightInformation>© 2022 The Author(s).</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Fleming Martinez</LastName>
            <ForeName>Alicia K</ForeName>
            <Initials>AK</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cancer Biology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Döppler</LastName>
            <ForeName>Heike R</ForeName>
            <Initials>HR</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cancer Biology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bastea</LastName>
            <ForeName>Ligia I</ForeName>
            <Initials>LI</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cancer Biology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Edenfield</LastName>
            <ForeName>Brandy H</ForeName>
            <Initials>BH</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cancer Biology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liou</LastName>
            <ForeName>Geou-Yarh</ForeName>
            <Initials>GY</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cancer Biology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Biological Sciences, Center for Cancer Research &amp; Therapeutic Development, Clark Atlanta University, Atlanta, GA 30314, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Storz</LastName>
            <ForeName>Peter</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cancer Biology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>04</Month>
          <Day>29</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>iScience</MedlineTA>
        <NlmUniqueID>101724038</NlmUniqueID>
        <ISSNLinking>2589-0042</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Cancer</Keyword>
        <Keyword MajorTopicYN="N">Immunology</Keyword>
        <Keyword MajorTopicYN="N">Microenvironment</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no competing interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>2</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>4</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>23</Day>
          <Hour>4</Hour>
          <Minute>32</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35602933</ArticleId>
        <ArticleId IdType="pmc">PMC9118688</ArticleId>
        <ArticleId IdType="doi">10.1016/j.isci.2022.104327</ArticleId>
        <ArticleId IdType="pii">S2589-0042(22)00598-3</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Agbunag C., Lee K.E., Buontempo S., Bar-Sagi D. Pancreatic duct epithelial cell isolation and cultivation in two-dimensional and three-dimensional culture systems. Methods Enzymol. 2006;407:703–710. doi: 10.1016/s0076-6879(05)07055-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0076-6879(05)07055-2</ArticleId>
            <ArticleId IdType="pubmed">16757363</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Akcora B.O., Storm G., Bansal R. Inhibition of canonical WNT signaling pathway by beta-catenin/CBP inhibitor ICG-001 ameliorates liver fibrosis in vivo through suppression of stromal CXCL12. Biochim. Biophys. Acta Mol. Basis Dis. 2018;1864:804–818. doi: 10.1016/j.bbadis.2017.12.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbadis.2017.12.001</ArticleId>
            <ArticleId IdType="pubmed">29217140</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Apte M., Pirola R.C., Wilson J.S. Pancreatic stellate cell: physiologic role, role in fibrosis and cancer. Curr. Opin. Gastroenterol. 2015;31:416–423. doi: 10.1097/mog.0000000000000196.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/mog.0000000000000196</ArticleId>
            <ArticleId IdType="pubmed">26125317</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Apte M.V., Haber P.S., Applegate T.L., Norton I.D., McCaughan G.W., Korsten M.A., Pirola R.C., Wilson J.S. Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture. Gut. 1998;43:128–133. doi: 10.1136/gut.43.1.128.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/gut.43.1.128</ArticleId>
            <ArticleId IdType="pmc">PMC1727174</ArticleId>
            <ArticleId IdType="pubmed">9771417</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Apte M.V., Haber P.S., Darby S.J., Rodgers S.C., McCaughan G.W., Korsten M.A., Pirola R.C., Wilson J.S. Pancreatic stellate cells are activated by proinflammatory cytokines: implications for pancreatic fibrogenesis. Gut. 1999;44:534–541. doi: 10.1136/gut.44.4.534.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/gut.44.4.534</ArticleId>
            <ArticleId IdType="pmc">PMC1727467</ArticleId>
            <ArticleId IdType="pubmed">10075961</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Apte M.V., Park S., Phillips P.A., Santucci N., Goldstein D., Kumar R.K., Ramm G.A., Buchler M., Friess H., McCarroll J.A., et al.  Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells. Pancreas. 2004;29:179–187. doi: 10.1097/00006676-200410000-00002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00006676-200410000-00002</ArticleId>
            <ArticleId IdType="pubmed">15367883</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Apte M.V., Wilson J.S., Lugea A., Pandol S.J. A starring role for stellate cells in the pancreatic cancer microenvironment. Gastroenterology. 2013;144:1210–1219. doi: 10.1053/j.gastro.2012.11.037.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/j.gastro.2012.11.037</ArticleId>
            <ArticleId IdType="pmc">PMC3729446</ArticleId>
            <ArticleId IdType="pubmed">23622130</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bachem M.G., Schneider E., Gross H., Weidenbach H., Schmid R.M., Menke A., Siech M., Beger H., Grunert A., Adler G. Identification, culture, and characterization of pancreatic stellate cells in rats and humans. Gastroenterology. 1998;115:421–432. doi: 10.1016/s0016-5085(98)70209-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0016-5085(98)70209-4</ArticleId>
            <ArticleId IdType="pubmed">9679048</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bachem M.G., Schunemann M., Ramadani M., Siech M., Beger H., Buck A., Zhou S., Schmid-Kotsas A., Adler G. Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells. Gastroenterology. 2005;128:907–921. doi: 10.1053/j.gastro.2004.12.036.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/j.gastro.2004.12.036</ArticleId>
            <ArticleId IdType="pubmed">15825074</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bastea L.I., Liou G.Y., Pandey V., Fleming A.K., von Roemeling C.A., Doeppler H., Li Z., Qiu Y., Edenfield B., Copland J.A., et al.  Pomalidomide alters pancreatic macrophage populations to generate an immune-responsive environment at precancerous and cancerous lesions. Cancer Res. 2019;79:1535–1548. doi: 10.1158/0008-5472.can-18-1153.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/0008-5472.can-18-1153</ArticleId>
            <ArticleId IdType="pmc">PMC6445670</ArticleId>
            <ArticleId IdType="pubmed">30696657</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bever K.M., Sugar E.A., Bigelow E., Sharma R., Laheru D., Wolfgang C.L., Jaffee E.M., Anders R.A., De Jesus-Acosta A., Zheng L. The prognostic value of stroma in pancreatic cancer in patients receiving adjuvant therapy. HPB. 2015;17:292–298. doi: 10.1111/hpb.12334.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/hpb.12334</ArticleId>
            <ArticleId IdType="pmc">PMC4368391</ArticleId>
            <ArticleId IdType="pubmed">25250696</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boring L., Gosling J., Chensue S.W., Kunkel S.L., Farese R.V., Jr., Broxmeyer H.E., Charo I.F. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J. Clin. Invest. 1997;100:2552–2561. doi: 10.1172/jci119798.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/jci119798</ArticleId>
            <ArticleId IdType="pmc">PMC508456</ArticleId>
            <ArticleId IdType="pubmed">9366570</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Botta G.P., Reichert M., Reginato M.J., Heeg S., Rustgi A.K., Lelkes P.I. ERK2-regulated TIMP1 induces hyperproliferation of K-Ras(G12D)-transformed pancreatic ductal cells. Neoplasia. 2013;15:359–372. doi: 10.1593/neo.121708.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1593/neo.121708</ArticleId>
            <ArticleId IdType="pmc">PMC3612909</ArticleId>
            <ArticleId IdType="pubmed">23555182</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen Y., Kim J., Yang S., Wang H., Wu C.J., Sugimoto H., LeBleu V.S., Kalluri R. Type I collagen deletion in αSMA+ myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer. Cancer Cell. 2021;39:548–565.e6. doi: 10.1016/j.ccell.2021.02.007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ccell.2021.02.007</ArticleId>
            <ArticleId IdType="pmc">PMC8423173</ArticleId>
            <ArticleId IdType="pubmed">33667385</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>D'Costa Z., Jones K., Azad A., van Stiphout R., Lim S.Y., Gomes A.L., Kinchesh P., Smart S.C., Gillies McKenna W., Buffa F.M., et al.  Gemcitabine-induced TIMP1 attenuates therapy response and promotes tumor growth and liver metastasis in pancreatic cancer. Cancer Res. 2017;77:5952–5962. doi: 10.1158/0008-5472.can-16-2833.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/0008-5472.can-16-2833</ArticleId>
            <ArticleId IdType="pubmed">28765154</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Elahi-Gedwillo K.Y., Carlson M., Zettervall J., Provenzano P.P. Antifibrotic therapy disrupts stromal barriers and modulates the immune landscape in pancreatic ductal adenocarcinoma. Cancer Res. 2019;79:372–386. doi: 10.1158/0008-5472.can-18-1334.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/0008-5472.can-18-1334</ArticleId>
            <ArticleId IdType="pmc">PMC6335156</ArticleId>
            <ArticleId IdType="pubmed">30401713</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ene-Obong A., Clear A.J., Watt J., Wang J., Fatah R., Riches J.C., Marshall J.F., Chin-Aleong J., Chelala C., Gribben J.G., et al.  Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma. Gastroenterology. 2013;145:1121–1132. doi: 10.1053/j.gastro.2013.07.025.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/j.gastro.2013.07.025</ArticleId>
            <ArticleId IdType="pmc">PMC3896919</ArticleId>
            <ArticleId IdType="pubmed">23891972</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ernsting M.J., Hoang B., Lohse I., Undzys E., Cao P., Do T., Gill B., Pintilie M., Hedley D., Li S.D. Targeting of metastasis-promoting tumor-associated fibroblasts and modulation of pancreatic tumor-associated stroma with a carboxymethylcellulose-docetaxel nanoparticle. J. Control Release. 2015;206:122–130. doi: 10.1016/j.jconrel.2015.03.023.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jconrel.2015.03.023</ArticleId>
            <ArticleId IdType="pmc">PMC4409566</ArticleId>
            <ArticleId IdType="pubmed">25804872</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Garg B., Giri B., Modi S., Sethi V., Castro I., Umland O., Ban Y., Lavania S., Dawra R., Banerjee S., et al.  NFκB in pancreatic stellate cells reduces infiltration of tumors by cytotoxic T cells and killing of cancer cells, via up-regulation of CXCL12. Gastroenterology. 2018;155:880–891.e8. doi: 10.1053/j.gastro.2018.05.051.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/j.gastro.2018.05.051</ArticleId>
            <ArticleId IdType="pmc">PMC6679683</ArticleId>
            <ArticleId IdType="pubmed">29909021</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grunwald B., Harant V., Schaten S., Fruhschutz M., Spallek R., Hochst B., Stutzer K., Berchtold S., Erkan M., Prokopchuk O., et al.  Pancreatic premalignant lesions secrete tissue inhibitor of metalloproteinases-1, which activates hepatic stellate cells via CD63 signaling to create a premetastatic niche in the liver. Gastroenterology. 2016;151:1011–1024.e7. doi: 10.1053/j.gastro.2016.07.043.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/j.gastro.2016.07.043</ArticleId>
            <ArticleId IdType="pubmed">27506299</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Helms E.J., Berry M.W., Chaw R.C., DuFort C.C., Sun D., Onate M.K., Oon C., Bhattacharyya S., Sanford-Crane H., Horton W., et al.  Mesenchymal lineage heterogeneity underlies non-redundant functions of pancreatic cancer-associated fibroblasts. Cancer Discov. 2021;12:484–501.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8831457</ArticleId>
            <ArticleId IdType="pubmed">34548310</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hessmann E., Patzak M.S., Klein L., Chen N., Kari V., Ramu I., Bapiro T.E., Frese K.K., Gopinathan A., Richards F.M., et al.  Fibroblast drug scavenging increases intratumoural gemcitabine accumulation in murine pancreas cancer. Gut. 2018;67:497–507. doi: 10.1136/gutjnl-2016-311954.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/gutjnl-2016-311954</ArticleId>
            <ArticleId IdType="pmc">PMC5868285</ArticleId>
            <ArticleId IdType="pubmed">28077438</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hong F., Tuyama A., Lee T.F., Loke J., Agarwal R., Cheng X., Garg A., Fiel M.I., Schwartz M., Walewski J., et al.  Hepatic stellate cells express functional CXCR4: role in stromal cell-derived factor-1α-mediated stellate cell activation. Hepatology. 2009;49:2055–2067. doi: 10.1002/hep.22890.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.22890</ArticleId>
            <ArticleId IdType="pmc">PMC2893547</ArticleId>
            <ArticleId IdType="pubmed">19434726</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huet E., Jaroz C., Nguyen H.Q., Belkacemi Y., de la Taille A., Stavrinides V., Whitaker H. Stroma in normal and cancer wound healing. FEBS J. 2019;286:2909–2920. doi: 10.1111/febs.14842.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/febs.14842</ArticleId>
            <ArticleId IdType="pubmed">30958920</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Iredale J.P., Benyon R.C., Arthur M.J., Ferris W.F., Alcolado R., Winwood P.J., Clark N., Murphy G. Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis. Hepatology. 1996;24:176–184. doi: 10.1002/hep.510240129.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.510240129</ArticleId>
            <ArticleId IdType="pubmed">8707259</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jenkinson C., Elliott V., Menon U., Apostolidou S., Fourkala O.E., Gentry-Maharaj A., Pereira S.P., Jacobs I., Cox T.F., Greenhalf W., et al.  Evaluation in pre-diagnosis samples discounts ICAM-1 and TIMP-1 as biomarkers for earlier diagnosis of pancreatic cancer. J. Proteomics. 2015;113:400–402. doi: 10.1016/j.jprot.2014.10.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jprot.2014.10.001</ArticleId>
            <ArticleId IdType="pubmed">25316052</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jung K.K., Liu X.W., Chirco R., Fridman R., Kim H.R.C. Identification of CD63 as a tissue inhibitor of metalloproteinase-1 interacting cell surface protein. EMBO J. 2006;25:3934–3942. doi: 10.1038/sj.emboj.7601281.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.emboj.7601281</ArticleId>
            <ArticleId IdType="pmc">PMC1560352</ArticleId>
            <ArticleId IdType="pubmed">16917503</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kemp S.B., Steele N.G., Carpenter E.S., Donahue K.L., Bushnell G.G., Morris A.H., The S., Orbach S.M., Sirihorachai V.R., Nwosu Z.C., et al.  Pancreatic cancer is marked by complement-high blood monocytes and tumor-associated macrophages. Life Sci. Alliance. 2021;4 doi: 10.26508/lsa.202000935. e202000935.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.26508/lsa.202000935</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lachowski D., Cortes E., Rice A., Pinato D., Rombouts K., Del Rio Hernandez A. Matrix stiffness modulates the activity of MMP-9 and TIMP-1 in hepatic stellate cells to perpetuate fibrosis. Sci. Rep. 2019;9:7299. doi: 10.1038/s41598-019-43759-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41598-019-43759-6</ArticleId>
            <ArticleId IdType="pmc">PMC6514003</ArticleId>
            <ArticleId IdType="pubmed">31086224</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee J.J., Perera R.M., Wang H., Wu D.C., Liu X.S., Han S., Fitamant J., Jones P.D., Ghanta K.S., Kawano S., et al.  Stromal response to Hedgehog signaling restrains pancreatic cancer progression. Proc. Natl. Acad. Sci. U S A. 2014;111:E3091–E3100. doi: 10.1073/pnas.1411679111.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1411679111</ArticleId>
            <ArticleId IdType="pmc">PMC4121834</ArticleId>
            <ArticleId IdType="pubmed">25024225</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li F., Xu X., Geng J., Wan X., Dai H. The autocrine CXCR4/CXCL12 axis contributes to lung fibrosis through modulation of lung fibroblast activity. Exp. Ther. Med. 2020;19:1844–1854. doi: 10.3892/etm.2020.8433.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3892/etm.2020.8433</ArticleId>
            <ArticleId IdType="pmc">PMC7027131</ArticleId>
            <ArticleId IdType="pubmed">32104240</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liou G.Y., Bastea L., Fleming A., Doppler H., Edenfield B.H., Dawson D.W., Zhang L., Bardeesy N., Storz P. The presence of interleukin-13 at pancreatic ADM/PanIN lesions alters macrophage populations and mediates pancreatic tumorigenesis. Cell Rep. 2017;19:1322–1333. doi: 10.1016/j.celrep.2017.04.052.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.celrep.2017.04.052</ArticleId>
            <ArticleId IdType="pmc">PMC5510483</ArticleId>
            <ArticleId IdType="pubmed">28514653</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liou G.Y., Doppler H., DelGiorno K.E., Zhang L., Leitges M., Crawford H.C., Murphy M.P., Storz P. Mutant KRas-induced mitochondrial oxidative stress in acinar cells upregulates EGFR signaling to drive formation of pancreatic precancerous lesions. Cell Rep. 2016;14:2325–2336. doi: 10.1016/j.celrep.2016.02.029.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.celrep.2016.02.029</ArticleId>
            <ArticleId IdType="pmc">PMC4794374</ArticleId>
            <ArticleId IdType="pubmed">26947075</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liou G.Y., Doppler H., Necela B., Edenfield B., Zhang L., Dawson D.W., Storz P. Mutant KRAS-induced expression of ICAM-1 in pancreatic acinar cells causes attraction of macrophages to expedite the formation of precancerous lesions. Cancer Discov. 2015;5:52–63. doi: 10.1158/2159-8290.cd-14-0474.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/2159-8290.cd-14-0474</ArticleId>
            <ArticleId IdType="pmc">PMC4293204</ArticleId>
            <ArticleId IdType="pubmed">25361845</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liou G.Y., Doppler H., Necela B., Krishna M., Crawford H.C., Raimondo M., Storz P. Macrophage-secreted cytokines drive pancreatic acinar-to-ductal metaplasia through NF-κB and MMPs. J. Cell Biol. 2013;202:563–577. doi: 10.1083/jcb.201301001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1083/jcb.201301001</ArticleId>
            <ArticleId IdType="pmc">PMC3734091</ArticleId>
            <ArticleId IdType="pubmed">23918941</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu Q., Wu H., Li Y., Zhang R., Kleeff J., Zhang X., Cui M., Liu J., Li T., Gao J., et al.  Combined blockade of TGf-β1 and GM-CSF improves chemotherapeutic effects for pancreatic cancer by modulating tumor microenvironment. Cancer Immunol. Immunother. 2020;69:1477–1492. doi: 10.1007/s00262-020-02542-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00262-020-02542-7</ArticleId>
            <ArticleId IdType="pubmed">32285172</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lu B., Rutledge B.J., Gu L., Fiorillo J., Lukacs N.W., Kunkel S.L., North R., Gerard C., Rollins B.J. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J. Exp. Med. 1998;187:601–608. doi: 10.1084/jem.187.4.601.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1084/jem.187.4.601</ArticleId>
            <ArticleId IdType="pmc">PMC2212142</ArticleId>
            <ArticleId IdType="pubmed">9463410</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Manoukian P., Bijlsma M., van Laarhoven H. The cellular origins of cancer-associated fibroblasts and their opposing contributions to pancreatic cancer growth. Front. Cell Dev. Biol. 2021;9:743907. doi: 10.3389/fcell.2021.743907.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fcell.2021.743907</ArticleId>
            <ArticleId IdType="pmc">PMC8502878</ArticleId>
            <ArticleId IdType="pubmed">34646829</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moffitt R.A., Marayati R., Flate E.L., Volmar K.E., Loeza S.G., Hoadley K.A., Rashid N.U., Williams L.A., Eaton S.C., Chung A.H., et al.  Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma. Nat. Genet. 2015;47:1168–1178. doi: 10.1038/ng.3398.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ng.3398</ArticleId>
            <ArticleId IdType="pmc">PMC4912058</ArticleId>
            <ArticleId IdType="pubmed">26343385</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ohlund D., Handly-Santana A., Biffi G., Elyada E., Almeida A.S., Ponz-Sarvise M., Corbo V., Oni T.E., Hearn S.A., Lee E.J., et al.  Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer. J. Exp. Med. 2017;214:579–596. doi: 10.1084/jem.20162024.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1084/jem.20162024</ArticleId>
            <ArticleId IdType="pmc">PMC5339682</ArticleId>
            <ArticleId IdType="pubmed">28232471</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Olive K.P., Jacobetz M.A., Davidson C.J., Gopinathan A., McIntyre D., Honess D., Madhu B., Goldgraben M.A., Caldwell M.E., Allard D., et al.  Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science. 2009;324:1457–1461. doi: 10.1126/science.1171362.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.1171362</ArticleId>
            <ArticleId IdType="pmc">PMC2998180</ArticleId>
            <ArticleId IdType="pubmed">19460966</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ozdemir B.C., Pentcheva-Hoang T., Carstens J.L., Zheng X., Wu C.C., Simpson T.R., Laklai H., Sugimoto H., Kahlert C., Novitskiy S.V., et al.  Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell. 2014;25:719–734. doi: 10.1016/j.ccr.2014.04.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ccr.2014.04.005</ArticleId>
            <ArticleId IdType="pmc">PMC4180632</ArticleId>
            <ArticleId IdType="pubmed">24856586</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pandey V., Fleming-Martinez A., Bastea L., Doeppler H.R., Eisenhauer J., Le T., Edenfield B., Storz P. CXCL10/CXCR3 signaling contributes to an inflammatory microenvironment and its blockade enhances progression of murine pancreatic precancerous lesions. Elife. 2021;10:e60646. doi: 10.7554/elife.60646.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7554/elife.60646</ArticleId>
            <ArticleId IdType="pmc">PMC8360647</ArticleId>
            <ArticleId IdType="pubmed">34328416</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Perez V.M., Kearney J.F., Yeh J.J. The PDAC extracellular matrix: a review of the ECM protein composition, tumor cell interaction, and therapeutic strategies. Front. Oncol. 2021;11:751311. doi: 10.3389/fonc.2021.751311.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fonc.2021.751311</ArticleId>
            <ArticleId IdType="pmc">PMC8526858</ArticleId>
            <ArticleId IdType="pubmed">34692532</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Phillips P.A., McCarroll J.A., Park S., Wu M.J., Pirola R., Korsten M., Wilson J.S., Apte M.V. Rat pancreatic stellate cells secrete matrix metalloproteinases: implications for extracellular matrix turnover. Gut. 2003;52:275–282. doi: 10.1136/gut.52.2.275.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/gut.52.2.275</ArticleId>
            <ArticleId IdType="pmc">PMC1774949</ArticleId>
            <ArticleId IdType="pubmed">12524413</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Phillips R.J., Burdick M.D., Hong K., Lutz M.A., Murray L.A., Xue Y.Y., Belperio J.A., Keane M.P., Strieter R.M. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J. Clin. Invest. 2004;114:438–446. doi: 10.1172/jci200420997.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/jci200420997</ArticleId>
            <ArticleId IdType="pmc">PMC484979</ArticleId>
            <ArticleId IdType="pubmed">15286810</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Poruk K.E., Firpo M.A., Scaife C.L., Adler D.G., Emerson L.L., Boucher K.M., Mulvihill S.J. Serum osteopontin and tissue inhibitor of metalloproteinase 1 as diagnostic and prognostic biomarkers for pancreatic adenocarcinoma. Pancreas. 2013;42:193–197. doi: 10.1097/mpa.0b013e31825e354d.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/mpa.0b013e31825e354d</ArticleId>
            <ArticleId IdType="pmc">PMC3576824</ArticleId>
            <ArticleId IdType="pubmed">23407481</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Provenzano P.P., Cuevas C., Chang A.E., Goel V.K., Von Hoff D.D., Hingorani S.R. Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma. Cancer Cell. 2012;21:418–429. doi: 10.1016/j.ccr.2012.01.007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ccr.2012.01.007</ArticleId>
            <ArticleId IdType="pmc">PMC3371414</ArticleId>
            <ArticleId IdType="pubmed">22439937</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rhim A.D., Oberstein P.E., Thomas D.H., Mirek E.T., Palermo C.F., Sastra S.A., Dekleva E.N., Saunders T., Becerra C.P., Tattersall I.W., et al.  Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma. Cancer Cell. 2014;25:735–747. doi: 10.1016/j.ccr.2014.04.021.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ccr.2014.04.021</ArticleId>
            <ArticleId IdType="pmc">PMC4096698</ArticleId>
            <ArticleId IdType="pubmed">24856585</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schneider C.A., Rasband W.S., Eliceiri K.W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods. 2012;9:671–675. doi: 10.1038/nmeth.2089.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nmeth.2089</ArticleId>
            <ArticleId IdType="pmc">PMC5554542</ArticleId>
            <ArticleId IdType="pubmed">22930834</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shi C., Washington M.K., Chaturvedi R., Drosos Y., Revetta F.L., Weaver C.J., Buzhardt E., Yull F.E., Blackwell T.S., Sosa-Pineda B., et al.  Fibrogenesis in pancreatic cancer is a dynamic process regulated by macrophage-stellate cell interaction. Lab. Invest. 2014;94:409–421. doi: 10.1038/labinvest.2014.10.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/labinvest.2014.10</ArticleId>
            <ArticleId IdType="pmc">PMC3992484</ArticleId>
            <ArticleId IdType="pubmed">24535260</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sparmann G., Hohenadl C., Tornoe J., Jaster R., Fitzner B., Koczan D., Thiesen H.J., Glass A., Winder D., Liebe S., Emmrich J. Generation and characterization of immortalized rat pancreatic stellate cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2004;287:G211–G219. doi: 10.1152/ajpgi.00347.2003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpgi.00347.2003</ArticleId>
            <ArticleId IdType="pubmed">14977634</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stanley E.R., Berg K.L., Einstein D.B., Lee P.S., Pixley F.J., Wang Y., Yeung Y.G. Biology and action of colony--stimulating factor-1. Mol. Reprod. Dev. 1997;46:4–10. doi: 10.1002/(SICI)1098-2795(199701)46:1&lt;4::AID-MRD2&gt;3.0.CO;2-V.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/(SICI)1098-2795(199701)46:1&lt;4::AID-MRD2&gt;3.0.CO;2-V</ArticleId>
            <ArticleId IdType="pubmed">8981357</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Storz P., Crawford H.C. Carcinogenesis of pancreatic ductal adenocarcinoma. Gastroenterology. 2020;158:2072–2081. doi: 10.1053/j.gastro.2020.02.059.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/j.gastro.2020.02.059</ArticleId>
            <ArticleId IdType="pmc">PMC7282937</ArticleId>
            <ArticleId IdType="pubmed">32199881</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tan Y., Li X., Tian Z., Chen S., Zou J., Lian G., Chen S., Huang K., Chen Y. TIMP1 down-regulation enhances gemcitabine sensitivity and reverses chemoresistance in pancreatic cancer. Biochem. Pharmacol. 2021;189:114085. doi: 10.1016/j.bcp.2020.114085.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bcp.2020.114085</ArticleId>
            <ArticleId IdType="pubmed">32522594</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tjomsland V., Pomianowska E., Aasrum M., Sandnes D., Verbeke C.S., Gladhaug I.P. Profile of MMP and TIMP expression in human pancreatic stellate cells: regulation by IL-1α and TGFβ and implications for migration of pancreatic cancer cells. Neoplasia. 2016;18:447–456. doi: 10.1016/j.neo.2016.06.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neo.2016.06.003</ArticleId>
            <ArticleId IdType="pmc">PMC4954934</ArticleId>
            <ArticleId IdType="pubmed">27435927</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Torphy R.J., Wang Z., True-Yasaki A., Volmar K.E., Rashid N., Yeh B., Anderson J.M., Johansen J.S., Hollingsworth M.A., Yeh J.J., Collisson E.A. Stromal content is correlated with tissue site, contrast retention, and survival in pancreatic adenocarcinoma. JCO Precis Oncol. 2018;2018 doi: 10.1200/po.17.00121. PO.17.00121.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1200/po.17.00121</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Whittle M.C., Izeradjene K., Rani P.G., Feng L., Carlson M.A., DelGiorno K.E., Wood L.D., Goggins M., Hruban R.H., Chang A.E., et al.  RUNX3 controls a metastatic switch in pancreatic ductal adenocarcinoma. Cell. 2015;161:1345–1360. doi: 10.1016/j.cell.2015.04.048.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2015.04.048</ArticleId>
            <ArticleId IdType="pmc">PMC4458240</ArticleId>
            <ArticleId IdType="pubmed">26004068</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu J., Mora A., Shim H., Stecenko A., Brigham K.L., Rojas M. Role of the SDF-1/CXCR4 axis in the pathogenesis of lung injury and fibrosis. Am. J. Respir. Cell Mol. Biol. 2007;37:291–299. doi: 10.1165/rcmb.2006-0187oc.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1165/rcmb.2006-0187oc</ArticleId>
            <ArticleId IdType="pmc">PMC1994230</ArticleId>
            <ArticleId IdType="pubmed">17463394</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yoshiji H., Kuriyama S., Miyamoto Y., Thorgeirsson U.P., Gomez D.E., Kawata M., Yoshii J., Ikenaka Y., Noguchi R., Tsujinoue H., et al.  Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model. Hepatology. 2000;32:1248–1254. doi: 10.1053/jhep.2000.20521.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/jhep.2000.20521</ArticleId>
            <ArticleId IdType="pubmed">11093731</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang X., Goncalves R., Mosser D.M. The isolation and characterization of murine macrophages. Curr. Protoc. Immunol. 2008 doi: 10.1002/0471142735.im1401s83. Chapter 83, Unit 14 11.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/0471142735.im1401s83</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
